Logo image of PFE

PFIZER INC (PFE) Stock Fundamental Analysis

NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD

23.49  +0.2 (+0.86%)

After market: 23.53 +0.04 (+0.17%)

Fundamental Rating

6

Taking everything into account, PFE scores 6 out of 10 in our fundamental rating. PFE was compared to 193 industry peers in the Pharmaceuticals industry. PFE has an excellent profitability rating, but there are some minor concerns on its financial health. PFE is valued quite cheap, while showing a decent growth score. This is a good combination! Finally PFE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PFE was profitable.
In the past year PFE had a positive cash flow from operations.
Each year in the past 5 years PFE has been profitable.
In the past 5 years PFE always reported a positive cash flow from operatings.
PFE Yearly Net Income VS EBIT VS OCF VS FCFPFE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.79%, PFE belongs to the top of the industry, outperforming 86.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.73%, PFE belongs to the top of the industry, outperforming 86.60% of the companies in the same industry.
PFE's Return On Invested Capital of 7.77% is amongst the best of the industry. PFE outperforms 85.05% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PFE is below the industry average of 14.92%.
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROIC 7.77%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)11.29%
ROIC(5y)11.14%
PFE Yearly ROA, ROE, ROICPFE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

PFE has a better Profit Margin (12.62%) than 89.18% of its industry peers.
PFE's Profit Margin has declined in the last couple of years.
PFE has a Operating Margin of 27.12%. This is amongst the best in the industry. PFE outperforms 93.81% of its industry peers.
PFE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 74.57%, PFE belongs to the top of the industry, outperforming 82.99% of the companies in the same industry.
In the last couple of years the Gross Margin of PFE has declined.
Industry RankSector Rank
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
PFE Yearly Profit, Operating, Gross MarginsPFE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PFE is still creating some value.
The number of shares outstanding for PFE has been increased compared to 1 year ago.
The number of shares outstanding for PFE has been increased compared to 5 years ago.
The debt/assets ratio for PFE has been reduced compared to a year ago.
PFE Yearly Shares OutstandingPFE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE Yearly Total Debt VS Total AssetsPFE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

An Altman-Z score of 2.11 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
PFE has a better Altman-Z score (2.11) than 67.53% of its industry peers.
The Debt to FCF ratio of PFE is 5.54, which is a neutral value as it means it would take PFE, 5.54 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PFE (5.54) is better than 82.99% of its industry peers.
PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating PFE is somewhat dependend on debt financing.
The Debt to Equity ratio of PFE (0.65) is worse than 65.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Altman-Z 2.11
ROIC/WACC0.88
WACC8.78%
PFE Yearly LT Debt VS Equity VS FCFPFE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 1.26 indicates that PFE should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, PFE is not doing good in the industry: 77.32% of the companies in the same industry are doing better.
PFE has a Quick Ratio of 1.26. This is a bad value and indicates that PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
PFE has a Quick ratio of 0.96. This is in the lower half of the industry: PFE underperforms 77.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.96
PFE Yearly Current Assets VS Current LiabilitesPFE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 126.06% over the past year.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
PFE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.65%.
Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%

3.2 Future

PFE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.69% yearly.
Based on estimates for the next years, PFE will show a decrease in Revenue. The Revenue will decrease by -2.58% on average per year.
EPS Next Y-2.62%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
EPS Next 5Y-3.69%
Revenue Next Year-0.79%
Revenue Next 2Y-0.73%
Revenue Next 3Y-1.13%
Revenue Next 5Y-2.58%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFE Yearly Revenue VS EstimatesPFE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE Yearly EPS VS EstimatesPFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.32, which indicates a rather cheap valuation of PFE.
Compared to the rest of the industry, the Price/Earnings ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 92.78% of the companies listed in the same industry.
PFE is valuated cheaply when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.52, the valuation of PFE can be described as very cheap.
Based on the Price/Forward Earnings ratio, PFE is valued cheaply inside the industry as 88.66% of the companies are valued more expensively.
PFE is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.32
Fwd PE 7.52
PFE Price Earnings VS Forward Price EarningsPFE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

PFE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PFE is cheaper than 93.30% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PFE is valued cheaper than 89.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.9
EV/EBITDA 6.78
PFE Per share dataPFE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PFE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)6.89
EPS Next 2Y0.25%
EPS Next 3Y0.22%

7

5. Dividend

5.1 Amount

PFE has a Yearly Dividend Yield of 7.39%, which is a nice return.
Compared to an average industry Dividend Yield of 4.21, PFE pays a better dividend. On top of this PFE pays more dividend than 98.45% of the companies listed in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 7.39%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.30%.
PFE has been paying a dividend for at least 10 years, so it has a reliable track record.
PFE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.3%
Div Incr Years14
Div Non Decr Years14
PFE Yearly Dividends per sharePFE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

PFE pays out 121.49% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP121.49%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
PFE Yearly Income VS Free CF VS DividendPFE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE Dividend Payout.PFE Dividend Payout, showing the Payout Ratio.PFE Dividend Payout.PayoutRetained Earnings

PFIZER INC

NYSE:PFE (8/1/2025, 8:04:00 PM)

After market: 23.53 +0.04 (+0.17%)

23.49

+0.2 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners67.59%
Inst Owner Change-0.06%
Ins Owners0.02%
Ins Owner Change1.75%
Market Cap133.55B
Analysts70
Price Target29.34 (24.9%)
Short Float %1.75%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield 7.39%
Yearly Dividend1.68
Dividend Growth(5Y)3.3%
DP121.49%
Div Incr Years14
Div Non Decr Years14
Ex-Date07-25 2025-07-25 (0.43)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.98%
Min EPS beat(2)32.52%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)42.48%
Min EPS beat(4)30.28%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)54.64%
EPS beat(12)12
Avg EPS beat(12)42.48%
EPS beat(16)16
Avg EPS beat(16)36.05%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)4.42%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)4
Avg Revenue beat(8)1.74%
Revenue beat(12)8
Avg Revenue beat(12)3.23%
Revenue beat(16)10
Avg Revenue beat(16)2.93%
PT rev (1m)0.67%
PT rev (3m)-1.26%
EPS NQ rev (1m)2.66%
EPS NQ rev (3m)0.88%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)1.17%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)-0.6%
Valuation
Industry RankSector Rank
PE 7.32
Fwd PE 7.52
P/S 2.14
P/FCF 11.9
P/OCF 9.55
P/B 1.48
P/tB N/A
EV/EBITDA 6.78
EPS(TTM)3.21
EY13.67%
EPS(NY)3.13
Fwd EY13.3%
FCF(TTM)1.97
FCFY8.4%
OCF(TTM)2.46
OCFY10.47%
SpS10.99
BVpS15.89
TBVpS-5.64
PEG (NY)N/A
PEG (5Y)6.89
Profitability
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROCE 9.87%
ROIC 7.77%
ROICexc 8.64%
ROICexgc 41.11%
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
FCFM 17.96%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)11.29%
ROIC(5y)11.14%
ROICexc(3y)12.95%
ROICexc(5y)13.16%
ROICexgc(3y)51.69%
ROICexgc(5y)47.96%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Debt/EBITDA 2.45
Cap/Depr 40.16%
Cap/Sales 4.43%
Interest Coverage 5.35
Cash Conversion 58.69%
Profit Quality 142.33%
Current Ratio 1.26
Quick Ratio 0.96
Altman-Z 2.11
F-Score8
WACC8.78%
ROIC/WACC0.88
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
EPS Next Y-2.62%
EPS Next 2Y0.25%
EPS Next 3Y0.22%
EPS Next 5Y-3.69%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%
Revenue Next Year-0.79%
Revenue Next 2Y-0.73%
Revenue Next 3Y-1.13%
Revenue Next 5Y-2.58%
EBIT growth 1Y56.33%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year21.61%
EBIT Next 3Y6.42%
EBIT Next 5Y3.52%
FCF growth 1Y-44.47%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y-41.56%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%